Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed vs Weight-Based Enoxaparin in Thoracic Surgery
NCT03251963Phase 2Completed
- Sponsor
- University of Utah
- Start
- Sep 2017
- Primary completion
- Mar 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in venous thromboembolism (VTE), sponsored by University of Utah. Started Sep 2017; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03251963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03251963.